Moxoron-0.3 Tablet

Moxonidine 0.3 mg

Moxoron-0.3 Tablet — Moxonidine 0.3 mg from Trumac Healthcare PCD Pharma Franchise India

Composition Moxonidine 0.3 mg
Dosage Form Tablet
Pack Type Box
Pack Size 10 x 10 (Alu-Alu)
MRP ₹ 950
Therapy Cardiac + Diabetic — Selective imidazoline I1 receptor agonist (centrally acting antihypertensive)
Storage Store below 25°C.

📱 WhatsApp Enquiry📞 Call: +919041677932

About Moxoron-0.3 Tablet

Moxoron-0.3 Tablet contains Moxonidine 0.3 mg. Moxonidine is a second-generation centrally acting antihypertensive that selectively binds imidazoline I1 receptors in the rostral ventrolateral medulla, reducing central sympathetic outflow.

Indicated for mild-to-moderate essential hypertension, particularly in patients with concurrent metabolic syndrome, insulin resistance, or those intolerant to ACE inhibitors, ARBs or thiazides.

Camrut Healthcare manufactures the Moxoron range under WHO-GMP conditions for PCD pharma franchise across India.

Indications

  • Mild-to-moderate essential hypertension
  • Hypertension with metabolic syndrome
  • Hypertension in patients intolerant to first-line agents
  • Adjunctive therapy in resistant hypertension

Mechanism of Action

Moxonidine selectively binds imidazoline I1 receptors in the rostral ventrolateral medulla, reducing central sympathetic outflow. The I1 selectivity gives it fewer side effects than older clonidine-class agents (less sedation, dry mouth, rebound hypertension). It also has favourable effects on insulin sensitivity.

Dosage & Administration

['Initial: 0.2 mg once daily', 'Maintenance: 0.2–0.6 mg/day in 1–2 divided doses', 'Maximum 0.6 mg/day', 'Take with breakfast']

Side Effects

['Dry mouth (less than clonidine)', 'Headache', 'Fatigue', 'Dizziness', 'Sleep disturbance occasionally']

Contraindications & Precautions

['Sick sinus syndrome', '2nd/3rd degree AV block', 'Severe bradycardia', 'Severe heart failure', 'Severe renal impairment', 'Pregnancy']

Storage

Store below 25°C.

PCD Pharma Franchise & Third-Party Manufacturing
Moxoron-0.3 Tablet is available for monopoly-based PCD pharma franchise across India and for third-party manufacturing under your brand. WHO-GMP certified, with full visual-aid and promotional support. Become a Trumac franchise partner →

Frequently Asked Questions

q

a

q

a

q

a

q

a

q

a

Related Products

B2B Disclaimer: This page is part of a Business-to-Business (B2B) pharmaceutical catalog intended for distributors, PCD franchise partners and healthcare professionals. Information provided is for commercial and educational reference only. Not for consumer sale. Patients must not self-medicate; please consult a qualified medical practitioner. All trade inquiries are subject to valid Drug License and GST documentation.